The molecular targets of taurine confer anti-hyperlipidemic effects.

Life Sciences
Yuanyuan DongJinhui Tao

Abstract

Hyperlipidemia, an independent risk factor for atherosclerosis, is regarded as a lipid metabolism disorder associated with elevated plasma triglyceride and/or cholesterol. Genetic factors and unhealthy lifestyles, such as excess caloric intake and physical inactivity, can result in hyperlipidemia. Taurine, a sulfur-containing non-essential amino acid, is abundant in marine foods and has been associated with wide-ranging beneficial physiological effects, with special reference to regulating aberrant lipid metabolism. Its anti-hyperlipidemic mechanism is complex, which is related to many enzymes in the process of fat anabolism and catabolism (e.g., HMGCR, CYP7A1, LDLR, FXR, FAS and ACC). Anti-inflammatory and antioxidant molecular targets, lipid autophagy, metabolic reprogramming and gut microbiota will also be reviewed.

References

Jan 1, 1992·Physiological Reviews·R J Huxtable
Dec 1, 1989·Journal of Nutritional Science and Vitaminology·K SugiyamaH Takeuchi
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D K Spady, J M Dietschy
Apr 4, 1986·Science·M S Brown, J L Goldstein
Apr 13, 1999·Gastroenterology Clinics of North America·Z R VlahcevicR T Stravitz
Jun 11, 1999·Bioscience, Biotechnology, and Biochemistry·H MochizukiH Yokogoshi
Sep 17, 2002·Biological & Pharmaceutical Bulletin·Jale BalkanMüjdat Uysal
Oct 18, 2002·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·N Stefan, M Stumvoll
Jan 25, 2003·Annual Review of Biochemistry·David W Russell
May 31, 2003·Journal of Nutritional Science and Vitaminology·Naomichi NishimuraHidehiko Yokogoshi
Jul 15, 2003·American Journal of Physiology. Endocrinology and Metabolism·Ilana TaliorHagit Eldar-Finkelman
Aug 12, 2003·Advances in Experimental Medicine and Biology·Wen ChenHidehiko Yokogoshi
Aug 12, 2003·Advances in Experimental Medicine and Biology·Mi Young LeeSoon Ki Kim
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano
Mar 3, 2004·Neurochemical Research·Georgia B Schuller-Levis, Eunkyue Park
Mar 30, 2004·Diabetes·Daniel Duran-SandovalBart Staels
Jan 8, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Josep Maria Del BasCinta Bladé
Jun 3, 2005·Current Opinion in Clinical Nutrition and Metabolic Care·Anne BouloumiéRudi Busse
Nov 23, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H K Vincent, A G Taylor
Jan 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yanqiao ZhangPeter A Edwards
Feb 9, 2006·Clinical Science·Yoshihisa OkamotoPeter Libby
Apr 22, 2006·Endocrinology·Nobuyo Tsuboyama-KasaokaOsamu Ezaki
Nov 3, 2006·Digestive Diseases and Sciences·Si-Wen ChenWei-Fen Xie
Dec 13, 2006·Advances in Experimental Medicine and Biology·Nien Vinh LamHidehiko Yokogoshi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Related Papers

Mini Reviews in Medicinal Chemistry
Kishor S JainDilpesh P Jain
European Journal of Medicinal Chemistry
Nikhilesh AryaKishor S Jain
Nihon rinsho. Japanese journal of clinical medicine
S Yamashita
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
Marcia L Brackbill, Christine Sytsma
Annual Review of Nutrition
K C Hayes, J A Sturman
© 2021 Meta ULC. All rights reserved